Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Diagn Cytopathol ; 37(1): 48-50, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18973126

RESUMEN

Diagnosis of two distinct malignant entities existing concurrently and at the same location (synchronous malignancy) by fine- needle aspiration (FNA) is unusual but may occur. Small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) in particular is associated with an increased incidence of secondary tumor, likely due to associated immunodeficiency. Co-occurrence of some carcinomas such as squamous cell carcinoma (SCC), may show especially aggressive behavior. A 57-year-old Caucasian male presented with recurrent upper extremity lymphedema and diffuse lymphadenopathy of the axillary and cervical regions. FNA of a large cervical lymph node was diagnostic for both atypical lymphocytic proliferation and SCC. Flow cytometric analysis showed the atypical lymphocytic proliferation to be positive for CD5, CD23, CD19, CD20, HLA-DR, CD38, and the population was kappa light chain restricted. These cells were negative for CD-10 and FMC-7 antigens, suggesting a phenotype of B-cell SLL/CLL. We report a rare occurrence of metastatic SCC to a lymph node infiltrated by SLL/CLL. The diagnosis was achieved by a combination of cytomorphologic examination of FNA smears, immunohistochemical staining of cell block material, and flow cytometry on the sample obtained by FNA. To the best of our knowledge, only three cases of SCC metastasis to SLL/CLL diagnosed by FNA have been reported in the English literature. Though rare, awareness of such a possibility and careful cytological examination under the appropriate clinical conditions is warranted.


Asunto(s)
Carcinoma de Células Escamosas/diagnóstico , Leucemia Linfocítica Crónica de Células B/diagnóstico , Ganglios Linfáticos/patología , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Orofaríngeas/patología , Biomarcadores de Tumor/análisis , Biopsia con Aguja Fina , Carcinoma de Células Escamosas/secundario , Humanos , Leucemia Linfocítica Crónica de Células B/patología , Ganglios Linfáticos/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Neoplasias Primarias Múltiples/patología , Radiografía
2.
Mol Vis ; 12: 1706-14, 2006 Dec 29.
Artículo en Inglés | MEDLINE | ID: mdl-17213800

RESUMEN

PURPOSE: Bear bile has been used in Asia for over 3,000 years to treat visual disorders, yet its therapeutic potential remains unexplored in Western vision research. The purpose of this study was to test whether treatment of mice undergoing retinal degeneration with tauroursodeoxycholic acid (TUDCA), a primary constituent of bear bile, alters the course of degeneration. METHODS: Two retinal degeneration models were tested: the rd10 mouse, which has a point mutation in the gene encoding the beta subunit of rod phosphodiesterase, and light induced retinal damage (LIRD). For LIRD studies, albino Balb/C adult mice were subcutaneously injected with TUDCA (500 mg/kg body weight) or vehicle (0.15 M NaHCO(3)). Sixteen h later, each mouse received repeat injections. Half of each treatment group was then placed in bright light (10,000 lux) or dim light (200 lux) for seven h. At the end of exposure, animals were transferred to their regular housing. Electroretinograms (ERGs) were assessed 24 h later, mice sacrificed, eyes embedded in paraffin and sectioned, and retina sections assayed for morphology and apoptosis by TUNEL and anti-active caspase-3 immunoreactivity via fluorescent confocal microscopy. A subset of mice were sacrificed 8 and 15 days after exposure and retina sections analyzed for morphology and apoptosis. For rd10 studies, mice were injected subcutaneously with TUDCA or vehicle at postnatal (P) days 6, 9, 12, and 15. At p18, ERGs were recorded, mice were euthanized and eyes were harvested, fixed, and processed. Retinal sections were stained (toluidine blue), and retinal cell layers morphometrically analyzed by light microscopy. Consecutive sections were analyzed for apopotosis as above. RESULTS: By every measure, TUDCA greatly slowed retinal degeneration in LIRD and rd10 mice. ERG a-wave and b-wave amplitudes were greater in mice treated with TUDCA compared to those treated with vehicle. Retinas of TUDCA-treated mice had thicker outer nuclear layers, more photoreceptor cells, and more fully-developed photoreceptor outer segments. Finally, TUDCA treatments dramatically suppressed signs of apoptosis in both models. CONCLUSIONS: Systemic injection of TUDCA, a primary constituent of bear bile, profoundly suppressed apoptosis and preserved function and morphology of photoreceptor cells in two disparate mouse models of retinal degeneration. It may be that bear bile has endured so long in Asian pharmacopeias due to efficacy resulting from this anti-apoptotic and neuroprotective activity of TUDCA. These results also indicate that a systematic, clinical assessment of TUDCA may be warranted.


Asunto(s)
Bilis/química , Ceguera/prevención & control , Células Fotorreceptoras de Vertebrados/patología , Degeneración Retiniana/complicaciones , Ácido Tauroquenodesoxicólico/farmacología , Ursidae , Animales , Apoptosis/efectos de los fármacos , Ceguera/etiología , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 6 , Modelos Animales de Enfermedad , Electrorretinografía , Inyecciones Subcutáneas , Luz , Medicina Tradicional de Asia Oriental , Ratones , Ratones Mutantes , Hidrolasas Diéster Fosfóricas/genética , Células Fotorreceptoras de Vertebrados/efectos de los fármacos , Degeneración Retiniana/etiología , Degeneración Retiniana/genética , Degeneración Retiniana/fisiopatología , Ácido Tauroquenodesoxicólico/administración & dosificación , Ácido Tauroquenodesoxicólico/síntesis química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA